School of Medicine
UConn Health Adds Support Resources for Front-line Staff
Telehealth counseling, team debriefs, a comfort room, and daily meditation are among the offerings to prioritize the emotional well-being of burdened care and support staff.
Investigating Molecular Mechanisms Behind Inflammatory Responses
UConn researcher Dr. Vijay Rathinam has received a $2M NIH grant to better understand the impact of extracellular vesicles on our body's inflammatory responses.
UConn Health Minute: COVID-19 Precautions
The news surrounding COVID-19 seems to be ever-changing. UConn Health’s Chief of Infectious Diseases, Dr. Kevin Dieckhaus, offers some precautionary reminders as the coronavirus pandemic continues.
OR Team Shares 1st Dr. Richard Simon Award
The Dr. Richard Simon Excellence in Clinical Neurosciences Award goes to Ellen Benson, Shevonne White, and Georgia Priestley from UConn Health’s Operating Room.
(Surgical) Social Distancing
UConn Health’s orthopedic surgery residency program will continue surgical training with remote virtual reality technology.
Amidst COVID-19 Outbreak, UConn Researchers Working on Simple, Low-Cost CRISPR-based Diagnostic Test for Infectious Diseases
UConn researchers are working to develop a simple, low-cost method of testing for coronavirus and other infectious diseases.
UConn’s Dr. Anthony Alessi Looks Out For Connecticut in “Healthy Rounds”
Dr. Anthony Alessi is the host of “Healthy Rounds” on WTIC NewsTalk 1080. Since the outbreak of the coronavirus, the show has gone to a daily format from 6 p.m. to 7 p.m.
Shaping the Future of Adult Sickle Cell Care
UConn Health sickle cell disease expert Dr. Biree Andemariam is part of the global conversation on how to advance and improve the transition from pediatric to adult care.
Match Day 2020 – No Ceremony but Plenty to Celebrate
Even though the annual Match Day ceremony was not held today because of COVID-19 concerns, fourth-year UConn medical students still have a lot to celebrate. Out of the 100 students eligible for the National Residency Match Program, 98% of them secured a residency and the vast majority matched to one of their top three choices. […]
UConn Startup Meets Major Milestone for MS Treatment
ImStem Biotechnology, a biopharmaceutical company located in UConn’s Technology Incubation Program (TIP), recently announced the U.S. FDA has removed the clinical hold on ImStem’s Investigational New Drug (IND) to evaluate their cell product candidate for the treatment of multiple sclerosis.